The Society for Immunotherapy of Cancer, previously known as the International Society for Biological Therapy of Cancer, is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Society for Immunotherapy of Cancer, United States, covering academic research published from 2003 to 2023. Read More.
Open Access Percentage
91%
Total
Publications
174
Total Open
Publications
159
Total
Citations
2.1K
Open Access
Percentage
91%
Total
Publications
174
Total Open
Publications
159
Total
Citations
2.1K
Breakdown
Publisher Open
0%
Both
91%
Other Platform Open
0%
Closed
9%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 97%
155
Hybrid 1%
1
No Guarantees 2%
3
Other Platform Open
Domain 99%
157
Institution 12%
19
Other Internet 4%
6
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 156 |
Europe PMC | Domain | 150 |
University of Pittsburgh - D-Scholarship@Pitt | Institution | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 3 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 3 |
Columbia University - Columbia Academic Commons | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Savoie Mont Blanc | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inserm | Institution | 2 |